Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression

Oncology Letters

Volumn 6, Issue 5, 2013, Pages 1346-1350

  Yi Park, Song ^a   Hee Jung, Chang ^a   Song, Bokyung ^a   Park, Ock Jin ^b   Kim, Young Min ^a  

^a Hannam University Daedeok Valley Campus ^*  (South Korea)

^b Hannam University   (South Korea)

Author keywords

Epigallocatechin 3 gallate; Matrix metalloproteinase 9; Migration suppressing effects; p53; Vascular endothelial growth factor

Indexed keywords

EPIGALLOCATECHIN GALLATE; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN P53; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COLON CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PROTEIN EXPRESSION; WESTERN BLOTTING; WOUND HEALING;

EID: 84884468894     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1533     Document Type: Article

References (19)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. Murthy NS, Mukherjee S, Ray G and Ray A: Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies. J Postgrad Med 55: 45-54, 2009.
3. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV and Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
4. Yu J and Zhang L: The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331: 851-858, 2005.
5. Wang Z and Sun Y: Targeting p53 for Novel Anticancer Therapy. Transl Oncol 3: 1-12, 2010.
6. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, ArtemovD, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A: Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14: 34-44, 2000.
7. Horiuchi A, Imai T, Shimizu M, Oka K, Wang C, Nikaido T and Konishi I: Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells. Anticancer Res 22: 2697-2702, 2002.
8. Montero E, Abreu C and Tonino P: Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 134: 193-201, 2008.
9. Oh SY, Kwon HC, Kim SH, Jang JS, Kim MC, Kim KH, HanJY, Kim CO, Kim SJ, Jeong JS and Kim HJ: Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC Cancer 8: 123, 2008.
10. Dorai T and Aggarwal BB: Role of chemopreventive agents in cancer therapy. Cancer Lett 215: 129-140, 2004.
11. Narayanan BA: Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets 6: 711-727, 2006.
12. Guo RP, Zhong C, Shi M, Zhang CQ, Wei W, Zhang YQ and LiJQ: Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 132: 547-555, 2006.
13. Shimizu M, Shirakami Y and Moriwaki H: Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. Int J Mol Sci 9: 1034-1049, 2008.
14. Saharinen P, Eklund L, Pulkki K, Bono P and Alitalo K: VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 17: 347-362, 2011.
15. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9: 289-303, 1990.
16. Liang CC, Park AY and Guan JL: In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration invitro. Nat Protoc 2: 329-333, 2007.
17. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, FangB, Lee JJ and Roth JA: Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 58: 2288-2292, 1998.
18. Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM and ParkOJ: Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett 247: 115-121, 2007.
19. Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, LiuC, Ellis L, Liu W, Go VL and Brooks MN: Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 132: 2307-2311, 2002.